BioMed Central | Articles which cite: Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma.

Log on / register
Feedback | Support | My details

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma.
Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS
Mol Cancer 2006, 5:67
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	Diffuse glioma growth: a guerilla war. Claes A, Idema AJ, Wesseling P Acta Neuropathol 2007 Nov, 114:443-58 [PubMed Central] [PubMed] [Related articles]
2.	Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Li M, Ransohoff RM Prog Neurobiol 2008 Feb, 84:116-31 [PubMed Central] [PubMed] [Related articles]
3.	Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. Chen YC, Hsu HS, Chen YW, Tsai TH, How CK, Wang CY, Hung SC, Chang YL, Tsai ML, Lee YY, Ku HH, Chiou SH PLoS One 2008, 3:e2637 [PubMed Central] [PubMed] [Related articles]
4.	Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells. Nandi S, Ulasov IV, Tyler MA, Sugihara AQ, Molinero L, Han Y, Zhu ZB, Lesniak MS Cancer Res 2008 Jul 15, 68:5778-84 [PubMed Central] [PubMed] [Related articles]
5.	Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines. Jaksch M, Múnera J, Bajpai R, Terskikh A, Oshima RG Cancer Res 2008 Oct 1, 68:7882-6 [PubMed Central] [PubMed] [Related articles]
6.	In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines. Zito G, Richiusa P, Bommarito A, Carissimi E, Russo L, Coppola A, Zerilli M, Rodolico V, Criscimanna A, Amato M, Pizzolanti G, Galluzzo A, Giordano C PLoS One 2008, 3:e3544 [PubMed Central] [PubMed] [Related articles]
7.	c-Myc is required for maintenance of glioma cancer stem cells. Wang J, Wang H, Li Z, Wu Q, Lathia JD, McLendon RE, Hjelmeland AB, Rich JN PLoS One 2008, 3:e3769 [PubMed Central] [PubMed] [Related articles]
8.	The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. Bidlingmaier S, Zhu X, Liu B J Mol Med 2008 Sep, 86:1025-32 [PubMed Central] [PubMed] [Related articles]
9.	Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus. Mahller YY, Williams JP, Baird WH, Mitton B, Grossheim J, Saeki Y, Cancelas JA, Ratner N, Cripe TP PLoS One 2009, 4:e4235 [PubMed Central] [PubMed] [Related articles]
10.	Cancer stem cells, endothelial progenitors, and mesenchymal stem cells: "seed and soil" theory revisited. Lin EH, Jiang Y, Deng Y, Lapsiwala R, Lin T, Blau CA Gastrointest Cancer Res 2008 Jul, 2:169-74 [PubMed Central] [PubMed] [Related articles]
11.	Prostate cancer stem cells. Lang SH, Frame FM, Collins AT J Pathol 2009 Jan, 217:299-306 [PubMed Central] [PubMed] [Related articles]
12.	The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling. Lin L, Amin R, Gallicano GI, Glasgow E, Jogunoori W, Jessup JM, Zasloff M, Marshall JL, Shetty K, Johnson L, Mishra L, He AR Oncogene 2009 Feb 19, 28:961-72 [PubMed Central] [PubMed] [Related articles]
13.	Immunotherapeutic approaches for glioma. Okada H, Kohanbash G, Zhu X, Kastenhuber ER, Hoji A, Ueda R, Fujita M Crit Rev Immunol 2009, 29:1-42 [PubMed Central] [PubMed] [Related articles]
14.	Cryopreservation of neurospheres derived from human glioblastoma multiforme. Chong YK, Toh TB, Zaiden N, Poonepalli A, Leong SH, Ong CE, Yu Y, Tan PB, See SJ, Ng WH, Ng I, Hande MP, Kon OL, Ang BT, Tang C Stem Cells 2009 Jan, 27:29-39 [PubMed Central] [PubMed] [Related articles]
15.	Glioblastoma formation from cell population depleted of Prominin1-expressing cells. Nishide K, Nakatani Y, Kiyonari H, Kondo T PLoS One 2009, 4:e6869 [PubMed Central] [PubMed] [Related articles]
16.	Migratory neighbors and distant invaders: tumor-associated niche cells. Wels J, Kaplan RN, Rafii S, Lyden D Genes Dev 2008 Mar 1, 22:559-74 [PubMed Central] [PubMed] [Related articles]
17.	Brain cancer stem cells display preferential sensitivity to Akt inhibition. Eyler CE, Foo WC, LaFiura KM, McLendon RE, Hjelmeland AB, Rich JN Stem Cells 2008 Dec, 26:3027-36 [PubMed Central] [PubMed] [Related articles]
18.	The Implications of the Cancer Stem Cell Hypothesis for Neuro-Oncology and Neurology. Rich JN Future Neurol 2008 May 1, 3:265-273 [PubMed Central] [PubMed] [Related articles]
19.	Doublecortin induces mitotic microtubule catastrophe and inhibits glioma cell invasion. Santra M, Santra S, Roberts C, Zhang RL, Chopp M J Neurochem 2009 Jan, 108:231-45 [PubMed Central] [PubMed] [Related articles]
20.	Stemming cancer: functional genomics of cancer stem cells in solid tumors. Regenbrecht CR, Lehrach H, Adjaye J Stem Cell Rev 2008 Dec, 4:319-28 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 7 articles in BioMed Central

You can also check ISI Web of Science for additional citations (subscription required)

printer friendly

to [Help]

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us